U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Ga
Molecular Weight 66.9282
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 3

SHOW SMILES / InChI
Structure of GALLIUM CATION GA-67

SMILES

[Ga+3]

InChI

InChIKey=CKHJYUSOUQDYEN-OIOBTWANSA-N
InChI=1S/Ga/q+3/i1-3

HIDE SMILES / InChI
Gallium citrate Ga 67 is the citrate salt of the radioisotope gallium Ga 67. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization. Ga-67 scintigraphy (GS) cannot differentiate between tumor and acute inflammation. Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
GALLIUM CITRATE GA 67

Approved Use

Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Launch Date

2.01052799E11
Primary
GALLIUM CITRATE GA 67

Approved Use

Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Launch Date

2.01052799E11
Primary
GALLIUM CITRATE GA 67

Approved Use

Gallium Citrate Ga 67 Injection may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Launch Date

2.01052799E11

Sample Use Guides

DOSAGE AND ADMINISTRATION: The recommended adult (70 kg) dose of Gallium Citrate Ga 67 Injection is 74-185 MBq (2-5 mCi). Gallium Citrate Ga 67 Injection is intended for intravenous administration only
Route of Administration: Intravenous
Name Type Language
GALLIUM CATION GA-67
Common Name English
GALLIUM GA-67 CATION
Common Name English
GALLIUM (67GA)CATION
Common Name English
GALLIUM CATION GA 67
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C799
Created by admin on Sat Jun 26 14:58:48 UTC 2021 , Edited by admin on Sat Jun 26 14:58:48 UTC 2021
Code System Code Type Description
RXCUI
1546371
Created by admin on Sat Jun 26 14:58:48 UTC 2021 , Edited by admin on Sat Jun 26 14:58:48 UTC 2021
PRIMARY RxNorm
FDA UNII
99T03J52W0
Created by admin on Sat Jun 26 14:58:48 UTC 2021 , Edited by admin on Sat Jun 26 14:58:48 UTC 2021
PRIMARY
PUBCHEM
11240419
Created by admin on Sat Jun 26 14:58:48 UTC 2021 , Edited by admin on Sat Jun 26 14:58:48 UTC 2021
PRIMARY
DRUG BANK
DB14549
Created by admin on Sat Jun 26 14:58:48 UTC 2021 , Edited by admin on Sat Jun 26 14:58:48 UTC 2021
PRIMARY
NCI_THESAURUS
C92220
Created by admin on Sat Jun 26 14:58:48 UTC 2021 , Edited by admin on Sat Jun 26 14:58:48 UTC 2021
PRIMARY